Ilja Nolte
Senior Researcher of Statistical Genetics and Genetic Epidemiology
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Background/Objectives: Tacrolimus dosing traditionally relies on therapeutic drug monitoring in whole blood, while assessment in plasma may better reflect its effect and reveal overdosing impacting health-related quality of life (HRQoL). Methods: In this cross-sectional study, 898 kidney transplant recipients (KTRs) who were at least 12 months post-transplantation were included. Plasma and whole blood tacrolimus concentrations were compared using Passing–Bablok regression analyses and Bland–Altman plots. Furthermore, the relationship with daily tacrolimus dose and with HRQoL (mental component summary (MCS), physical component summary (PCS)) was explored using linear regression by comparing standardized coefficients. Lastly, mediation analyses explored the effect of various tacrolimus-related side effects on the association between tacrolimus concentrations and HRQoL. Results: Comparison of the methods revealed a constant bias and a slight proportional bias between whole blood and plasma tacrolimus concentrations. The Bland–Altman plots indicated poor agreement with a statistically significant ratio difference (p < 0.001). Both whole blood and plasma concentrations were significantly associated with daily tacrolimus dose (both p < 0.001). Compared to whole blood tacrolimus concentrations, plasma tacrolimus concentration showed a strong negative association with worse HRQoL (PCS: st. β = −0.12, p = 0.01; MCS: st. β = −0.14, p < 0.001). The associations between plasma tacrolimus concentrations and HRQoL were mediated by fatigue severity (proportion mediated on PCS: 67.8%, MCS: 59.5%) and reduced kidney function (proportion mediated on PCS: 16.7%, MCS: 12.9%). Conclusions: In conclusion, compared with whole blood tacrolimus concentrations, plasma tacrolimus concentrations exhibited a negative association with HRQoL in KTRs. Consequently, therapeutic drug monitoring using plasma tacrolimus concentrations may reduce the occurrence of tacrolimus-related toxicity.
Year:
2025
Social behaviour is a heritable, context-dependent trait that changes across social settings and development, influencing wellbeing and mental health. We present the first genome-wide meta-regression study of social behaviour from infancy to early adulthood, leveraging 491,246 repeat measures of low prosocial behaviour and peer/social difficulties in European-ancestry cohorts (N eff =121,777, N ind =73,321). We modelled heterogeneity in genetic effects across social domains, informants, and ages (2–29 years), capturing social context through genomic influences. Six loci were identified, including variation within CADM2 ( p =2.51x10 -9 ). The SNP-based heritability was modest (2–7%), and the genetic architecture of social behaviour multidimensional. Polygenic scores demonstrated predictability and accuracy in independent European-ancestry cohorts and, partially, in African-ancestry cohorts (N ind =16,305). Genetic correlations with later-life and mental health outcomes showed context-dependent patterns. Modelling predicted onsets of associations with social behaviour revealed distinct profiles, as observed for autism, ADHD, depression and schizophrenia, highlighting novel opportunities to genetically proxy developmental trajectories.
Year:
2025
Inflammation is associated with a range of neuropsychiatric symptoms; however, the nature of the causal relationship is unclear. We used complementary non-genetic, genetic risk score (GRS), and Mendelian randomization (MR) analyses to examine whether inflammatory markers are associated with affect, depressive and anxiety disorders, and cognition. We tested in ≈ 55,098 (59% female) individuals from the Dutch Lifelines cohort the concurrent/prospective associations of C-reactive protein (CRP) with: depressive and anxiety disorders; positive/negative affect; and attention, psychomotor speed, episodic memory, and executive functioning. Additionally, we examined the association between inflammatory GRSs (CRP, interleukin-6 [IL-6], IL-6 receptor [IL-6R and soluble IL-6R (sIL-6R)], glycoprotein acetyls [GlycA]) on these same outcomes (N max =57,946), followed by MR analysis examining evidence of causality of CRP on outcomes (N max =23,268). In non-genetic analyses, higher CRP was associated with a depressive disorder, lower positive/higher negative affect, and worse executive function, attention, and psychomotor speed after adjusting for potential confounders. In genetic analyses, CRP GRS was associated with any anxiety disorder (β = 0.002, p = 0.037) whereas GlycA GRS was associated with major depressive disorder (β = 0.001, p = 0.036). Both CRP GRS (β = 0.006, p = 0.035) and GlycA GRS (β = 0.006, p = 0.049) were associated with greater negative affect. Inflammatory GRSs were not associated with cognition, except sIL-6R GRS which was associated with poorer memory (β=-0.009, p = 0.018). There was weak evidence for a CRP-anxiety association using MR (β = 0.12; p = 0.054). Genetic and non-genetic analyses provide consistent evidence for an association between CRP and negative affect. These results suggest that dysregulated immune physiology may impact a broad range of trans-diagnostic affective symptoms.
Year:
2024
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes. Investigating these genes’ functional implications shed light on neurological, thyroidal, bone metabolism, and hematopoietic pathways that necessitate future investigation for blood pressure management that caters to sleep health lifestyle. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausible nature of distinct influences of both sleep duration extremes in cardiovascular health. Several of our loci are specific towards a particular population background or sex, emphasizing the importance of addressing heterogeneity entangled in gene-environment interactions, when considering precision medicine design approaches for blood pressure management.
Year:
2024
Background Low-grade systemic inflammation is implicated in the pathogenesis of various neuropsychiatric conditions affecting mood and cognition. While much of the evidence concerns depression, large-scale population studies of anxiety, affect, and cognitive function are scarce. Importantly, causality remains unclear. We used complementary non-genetic, genetic risk score (GRS), and Mendelian randomization (MR) analyses to examine whether inflammatory markers are associated with affect, depressive and anxiety disorders, and cognitive performance in the Lifelines Cohort; and whether associations are likely to be causal. Methods Using data from up to 55,098 (59% female) individuals from the Dutch Lifelines cohort, we tested the cross-sectional and longitudinal associations of C-reactive protein (CRP) with (i) depressive and anxiety disorders; (ii) positive and negative affect scores, and (iii) five cognitive measures assessing attention, psychomotor speed, episodic memory, and executive functioning (figural fluency and working memory). Additionally, we examined the association between inflammatory marker GRSs (CRP, interleukin-6 [IL-6], IL-6 receptor [IL-6R and soluble IL-6R (sIL-6R)], glycoprotein acetyls [GlycA]) on these same outcomes (N max =57,946), followed by MR analysis examining evidence of causality of CRP on outcomes (N max =23,268). In genetic analyses, all GRSs and outcomes were z-transformed. Results In non-genetic analyses, higher CRP was associated with diagnosis of any depressive disorder, lower positive and higher negative affect scores, and worse performance on tests of figural fluency, attention, and psychomotor speed after adjusting for potential confounders, although the magnitude of these associations was small. In genetic analyses, CRP GRS was associated with any anxiety disorder (β=0.002, p =0.037, N=57,047) whereas GlycA GRS was associated with major depressive disorder (β=0.001, p =0.036; N=57,047). Both CRP GRS (β=0.006, p =0.035, N=57,946) and GlycA GRS (β=0.006, p =0.049; N=57,946) were associated with higher negative affect score. Inflammatory marker GRSs were not associated with cognitive performance, except sIL-6R GRS which was associated with poorer memory performance (β=-0.009, p =0.018, N=36,783). Further examination of the CRP-anxiety association using MR provided some weak evidence of causality (β=0.12; p =0.054). Conclusions Genetic and non-genetic analyses provide consistent evidence for an association between CRP and negative affect. Genetic analyses suggest that IL-6 signaling could be relevant for memory, and that the association between CRP and anxiety disorders could be causal. These results suggest that dysregulated immune physiology may impact a broad range of trans-diagnostic affective symptoms. However, given the small effect sizes and multiple tests conducted, future studies are required to investigate whether effects are moderated by sub-groups and whether these findings replicate in other cohorts.
Year:
2024
Heavy metals are common in our environment, and all individuals are exposed to them to some extent. These toxic metals have several harmful effects on the body, including the kidney, which is a very sensitive organ. Indeed, heavy metal exposure has been linked to an increased risk of chronic kidney disease (CKD) and its progression, which may be explained by the well-established nephrotoxic effects of these metals. In this hypothesis and narrative literature review, we will shed light on the potential role that another highly common problem in patients with CKD, iron deficiency, may play in the damaging effects of heavy metal exposure in this patient group. Iron deficiency has previously been linked with an increased uptake of heavy metals in the intestine due to the upregulation of iron receptors that also take up other metals. Furthermore, recent research suggests a role of iron deficiency in the retention of heavy metals in the kidney. Therefore, we hypothesize that iron deficiency plays a crucial role in the damaging effects of heavy metal exposure in patients with CKD and that iron supplementation might be a strategy to combat these detrimental processes.
Year:
2023
Collaborators (93)
Xiaofeng Zhu
Professor
Case Western Reserve University
Harold Snieder
Scientific Staff
University Medical Center Groningen
Tomas Paus
Group leader
BarcelonaBeta Brain Research Center
Amy Bentley
National Human Genome Research Institute
Melissa Wake
Professorial Fellow
University of Melbourne
Angelica Ronald
Professor of Psychology and Genetics
University of Surrey
Cristina Menni
King’s College London
Eveline de Zeeuw
University of Amsterdam
Anni Malmberg
University of Helsinki
Nicholas Wareham
Director
University of Cambridge
Robert Plomin
Research Professor in Behavioural Genetics
King’s College London
Gibran Hemani
Academic , Professor in Statistical Genetics
University of Bristol
George Davey Smith
Academic , Professor of Clinical Epidemiology
University of Bristol
Ted Reichborn-Kjennerud
Professor
University of Oslo
Joseph McCormick
James H. Steele Professor
-
Alexander Neumann
Researcher
Erasmus University Rotterdam
Sanjeevan Jahagirdar
Max Planck Institute for Psycholinguistics
Alexandra Havdahl
Prof
Norwegian Institute of Public Health
Rosa Bosch
divisió de salut mental althaia xarxa assistencial universitària de manresa manresa
Golam Khandaker
Professor of Psychiatry and Immunology
University of Bristol
Carol Wang
University of Western Australia
Gea Drost
University Medical Center Groningen
Kaili Rimfeld
Lecturer (Assistant Professor) in Psychology
Royal Holloway, University of London
Vilmundur Gudnason
Professor
University of Iceland
Vincent W. V. Jaddoe
Erasmus MC
Chloe Slaney
University of Bristol
Simon R. Cox
Personal Chair of Brain and Cognitive Ageing
University of Edinburgh
Eero Vuoksimaa
University of Helsinki
Melissa H Black
Associate Professor
La Trobe University
Jennifer Ann Smith
Professor
University of Michigan
Michele F. Eisenga
University of Groningen
Sarah Harris
University of Edinburgh
Ching-Ti Liu
Boston University
Ko Willems van Dijk
Professor
Leiden University Medical Center
Jordi Sunyer Deu
Chair
Barcelona Institute for Global Health
massimo mangino
Honorary Senior Lecturer
King’s College London
Heming Wang
Assistant Professor
Brigham and Women's Hospital
Marta Ribases
-
Thomas Bourgeron
Université Paris Diderot
Catharina A. Hartman
-
Heather M Highland
University of North Carolina at Chapel Hill
Marcus Dörr
University Medicine Greifswald
Paul de Vries
Assistant Professor
The University of Texas Health Science Center at Houston School of Public Health
Lisa de las Fuentes
Professor of Medicine and Biostatistics
Washington University School of Medicine
Henning Tiemeier
Professor of Maternal and Child Health
Harvard T.H. Chan School of Public Health
Jan Buitelaar
Professor, Principal Investigator
Radboud University Medical Center
Iris M. Heid
University of Regensburg
Rodney Scott
Prof. of Medical Genetics
University of Newcastle Australia
Myriam Fornage
-
Changwei Li
Associate Professor
University of Texas Southwestern Medical Center
Mary Feitosa
Associate Professor
Washington University School of Medicine
Debbie A Lawlor
Academic , Professor of Epidemiology, MRC Investigator and BHF Chair
University of Bristol
Nora Fernandez-Jimenez
Assistant Professor in Genetics
University of the Basque Country
Sami Heikkinen
Research Director
University of Eastern Finland
Peter Y Liu
University of California
Kari North
Professor
University of North Carolina at Chapel Hill
Angela Morgan
University of Melbourne
Kisung Nam
Seoul National University
Tanja G M Vrijkotte
University of Amsterdam
Jose Ramon Bilbao
Full Professor
University of the Basque Country
Michael Province
Professor, Head Division of Statistical Genomics
Washington University in St. Louis
Josep Antoni Ramos-Quiroga
Head of the Deparment of Psychiatry
Hospital Universitari Vall d'Hebron
Mariona Bustamante
Staff scientist
Barcelona Institute for Global Health
Jari Lahti
Professor
University of Helsinki
Christel Middeldorp
Professor
-
Uwe Völker
Professor, Head of Department
Universitätsmedizin Greifswald
Alina Rodriguez
professor
University of Lincoln
Quan Sun
Research Assistant Professor
University of Pennsylvania
Tarunveer Singh Ahluwalia
Associate Professor
University of Copenhagen
Sheena Reilly
Griffith University
John Attia
University of Newcastle Australia
Marjo-Riitta Jarvelin
Professor
University of Oulu
Henrik Larsson
Professor
Karolinska Institutet
Nicholette Allred
Wake Forest Baptist Medical Center
Mariaelisa Graff
Assistant Professor
University of North Carolina
paul lichtenstein
Head of Department
Karolinska Institutet
Andrew Whitehouse
University of Western Australia
Ebba Du Rietz
Assistant Professor
Karolinska Institutet
Brian Cade
Investigator
Brigham and Women's Hospital
Charlotte Cecil
Associate Professor Biological Psychopathology
Erasmus MC
Johannes Björk
Scientific Staff
University Medical Center Groningen
Dan Stein
Professor and Chair of Psychiatry
University of Cape Town
Christine Ecker
Heisenberg Professor
Goethe University Frankfurt
Terho Lehtimäki
University of Tampere
Eivind Ystrom
Professor of personality psychology
University of Oslo
Sven Bölte
Professor, head of the Pediatric Neuropsychiatry Unit
Healthcare Provision, Stockholm County
Craig Pennell
Professor and Chair Obstetrics and Gynaecology, Professor Maternal Fetal Medicine
Newcastle University
SINA A. GHARIB
University of Washington
Teemu Palviainen
University of Helsinki
Jian'an Luan
University of Cambridge
Jaakko Kaprio
Research Director
University of Helsinki
Ellen Verhoef
Max Planck Institute for Psycholinguistics
Dorret I Boomsma
Full professor
University of Amsterdam
Make your next move.
Prepare your application
Review drafts before you send them.